Annual SGA
$20.80 M
-$28.00 K-0.13%
December 31, 2023
Summary
- As of February 8, 2025, INZY annual SGA is $20.80 million, with the most recent change of -$28.00 thousand (-0.13%) on December 31, 2023.
- During the last 3 years, INZY annual SGA has risen by +$10.25 million (+97.17%).
- INZY annual SGA is now -0.13% below its all-time high of $20.83 million, reached on December 31, 2022.
Performance
INZY SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$4.96 M
-$946.00 K-16.01%
September 30, 2024
Summary
- As of February 8, 2025, INZY quarterly SGA is $4.96 million, with the most recent change of -$946.00 thousand (-16.01%) on September 30, 2024.
- Over the past year, INZY quarterly SGA has dropped by -$946.00 thousand (-16.01%).
- INZY quarterly SGA is now -23.82% below its all-time high of $6.51 million, reached on March 31, 2023.
Performance
INZY Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.29 B
-$96.49 M-8.07%
September 30, 2024
Summary
- As of February 8, 2025, INZY TTM SGA is -$1.29 billion, with the most recent change of -$96.49 million (-8.07%) on September 30, 2024.
- Over the past year, INZY TTM SGA has dropped by -$1.31 billion (-6343.77%).
- INZY TTM SGA is now -3629.65% below its all-time high of -$34.65 million.
Performance
INZY TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
INZY Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.1% | -16.0% | -6343.8% |
| 3 y3 years | +97.2% | -12.9% | -6305.7% |
| 5 y5 years | +495.3% | -12.9% | -6305.7% |
INZY Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.1% | +9.9% | -23.8% | +5.1% | -161.9% | at low |
| 5 y | 5-year | -0.1% | +353.5% | -23.8% | +233.2% | -3629.7% | at low |
| alltime | all time | -0.1% | +495.3% | -23.8% | +394.6% | -3629.7% | at low |
Inozyme Pharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.96 M(-16.0%) | $20.93 M(+1.1%) |
| Jun 2024 | - | $5.91 M(+12.9%) | $20.70 M(+6.0%) |
| Mar 2024 | - | $5.23 M(+8.5%) | $19.52 M(-6.1%) |
| Dec 2023 | $20.80 M(-0.1%) | $4.83 M(+1.9%) | $20.80 M(-4.0%) |
| Sep 2023 | - | $4.73 M(+0.1%) | $21.67 M(+0.1%) |
| Jun 2023 | - | $4.73 M(-27.4%) | $21.66 M(-2.9%) |
| Mar 2023 | - | $6.51 M(+14.3%) | $22.31 M(+7.1%) |
| Dec 2022 | $20.83 M(+10.0%) | $5.70 M(+20.7%) | $20.83 M(+2.4%) |
| Sep 2022 | - | $4.72 M(-12.3%) | $20.34 M(-0.9%) |
| Jun 2022 | - | $5.38 M(+7.1%) | $20.53 M(+4.8%) |
| Mar 2022 | - | $5.03 M(-3.5%) | $19.58 M(+3.5%) |
| Dec 2021 | $18.93 M | $5.21 M(+5.9%) | $18.93 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $4.92 M(+10.8%) | $17.95 M(+11.0%) |
| Jun 2021 | - | $4.43 M(+1.5%) | $16.18 M(+20.6%) |
| Mar 2021 | - | $4.37 M(+3.2%) | $13.42 M(+27.2%) |
| Dec 2020 | $10.55 M(+130.0%) | $4.24 M(+34.8%) | $10.55 M(+35.2%) |
| Sep 2020 | - | $3.14 M(+88.0%) | $7.80 M(+37.8%) |
| Jun 2020 | - | $1.67 M(+11.4%) | $5.66 M(+12.0%) |
| Mar 2020 | - | $1.50 M(+0.7%) | $5.06 M(+10.2%) |
| Dec 2019 | $4.59 M(+31.3%) | $1.49 M(+48.5%) | $4.59 M(+48.1%) |
| Sep 2019 | - | $1.00 M(-5.7%) | $3.10 M(+47.9%) |
| Jun 2019 | - | $1.06 M(+3.3%) | $2.09 M(+103.3%) |
| Mar 2019 | - | $1.03 M | $1.03 M |
| Dec 2018 | $3.49 M | - | - |
FAQ
- What is Inozyme Pharma annual SGA?
- What is the all time high annual SGA for Inozyme Pharma?
- What is Inozyme Pharma annual SGA year-on-year change?
- What is Inozyme Pharma quarterly SGA?
- What is the all time high quarterly SGA for Inozyme Pharma?
- What is Inozyme Pharma quarterly SGA year-on-year change?
- What is Inozyme Pharma TTM SGA?
- What is the all time high TTM SGA for Inozyme Pharma?
- What is Inozyme Pharma TTM SGA year-on-year change?
What is Inozyme Pharma annual SGA?
The current annual SGA of INZY is $20.80 M
What is the all time high annual SGA for Inozyme Pharma?
Inozyme Pharma all-time high annual SGA is $20.83 M
What is Inozyme Pharma annual SGA year-on-year change?
Over the past year, INZY annual SGA has changed by -$28.00 K (-0.13%)
What is Inozyme Pharma quarterly SGA?
The current quarterly SGA of INZY is $4.96 M
What is the all time high quarterly SGA for Inozyme Pharma?
Inozyme Pharma all-time high quarterly SGA is $6.51 M
What is Inozyme Pharma quarterly SGA year-on-year change?
Over the past year, INZY quarterly SGA has changed by -$946.00 K (-16.01%)
What is Inozyme Pharma TTM SGA?
The current TTM SGA of INZY is -$1.29 B
What is the all time high TTM SGA for Inozyme Pharma?
Inozyme Pharma all-time high TTM SGA is -$34.65 M
What is Inozyme Pharma TTM SGA year-on-year change?
Over the past year, INZY TTM SGA has changed by -$1.31 B (-6343.77%)